中国原发性甲状旁腺功能亢进症诊治进展与临床特征演变
该综述系统回顾近年来国内外文献,梳理中国原发性甲状旁腺功能亢进症(PHPT)的诊治理论演进与技术革新。文章指出PHPT临床表型正从典型骨肾受累的重症向隐匿化、亚临床化转变,无症状型及正常血钙型PHPT显著增多。术前定位已从超声和核素扫描发展至四维CT及胆碱PET,为微创甲状旁腺切除术奠定基础,但基层认知不足、设备可及性失衡及多腺体病变处理仍存挑战。
要点
- 中国PHPT表型向亚临床化转变,无症状型与正常血钙型显著增多。
- 术前定位从超声、核素扫描迈入四维CT及胆碱PET时代。
- 精准定位支撑微创甲状旁腺切除术的广泛推广。
核心结论
- 中国PHPT临床表型正从骨肾受累的典型重症向隐匿化、亚临床化深刻转变,诊疗需更加精细化。
- 术前定位技术进步为微创甲状旁腺切除术的广泛推广奠定坚实基础。
研究设计与样本
- 本文为综述,系统回顾近年来国内外发表的相关文献。
主要发现
- 我国以无症状型PHPT和正常血钙型PHPT为代表的亚临床表型显著增多。
- 术前定位技术已从传统超声检查和放射性核素扫描,迈入四维CT及胆碱PET时代。
- 我国PHPT诊疗仍面临基层医师认知不足、高端影像设备可及性失衡、多腺体病变处理复杂等挑战。
临床怎么用
- 临床应关注亚临床型PHPT的识别,借助四维CT或胆碱PET进行精准术前定位以支持微创手术。
- 需加强基层医师对PHPT的认知,并重视多腺体病变处理的复杂性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary hyperparathyroidism (PHPT) is a common clinical endocrine and metabolic disorder. Its clinical phenotype spectrum is undergoing a profound shift, evolving from the classic, severe presentations characterized by bone and kidney involvement towards more occult and subclinical forms. With the increasing adoption of routine biochemical screening and advancements in diagnostic technologies, there has been a notable rise in subclinical phenotypes of PHPT in China, particularly asymptomatic PHPT and normocalcemic PHPT. This trend not only reflects the progress of Chinese public health system but also imposes higher demands for precision in clinical diagnosis and treatment. Meanwhile, preoperative localization techniques have evolved from traditional ultrasound and radionuclide scanning to the era of four-dimensional CT and choline positron emission tomography, laying a solid foundation for the widespread adoption of minimally invasive parathyroidectomy. However, the clinical management of PHPT in China still faces significant challenges, including insufficient awareness among primary care physicians, imbalanced accessibility to advanced imaging equipment, and the complexity of managing multi-gland disease. This review systematically examines relevant literature published both domestically and internationally in recent years. It aims to outline the theoretical evolution, technological advancements, and disease characteristics specific to the Chinese population, with the goal of providing a reference for the standardized diagnosis and treatment of PHPT in China. 原发性甲状旁腺功能亢进症(PHPT)是临床较为常见的内分泌代谢性疾病,其临床表型谱系正经历着从“骨与肾”的典型重症表型向“隐匿化、亚临床化”的深刻转变。随着常规生化筛查意识的提升与诊断技术的迭代,我国以无症状型PHPT和正常血钙型PHPT为代表的亚临床表型显著增多,这一转变不仅反映了我国公共卫生体系的进步,也对临床诊疗的精细化提出了更高要求。与此同时,术前精准定位技术已从传统的超声检查和放射性核素扫描,迈入四维CT及胆碱CT扫描时代,为微创入路甲状旁腺切除术的广泛推广奠定了坚实基础。然而,我国PHPT的临床诊疗仍面临部分基层医师对其认知不足、高端影像学设备可及性失衡、多腺体病变处理复杂等深层次现实挑战。本文系统回顾了近年来国内外发表的相关文献,梳理PHPT诊治的理论演进脉络、技术革新进展与中国人群PHPT的疾病特征,以期为我国PHPT的规范化诊疗提供参考。.
引用
- Gao JY, Liao Q. [Advances in the diagnosis and treatment of primary hyperparathyroidism and the evolution of its clinical characteristics in China]. Zhonghua Wai Ke Za Zhi. 2026. PMID: 42951843. doi:10.3760/cma.j.cn112139-20260601-00240
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。